QQ客服 官方微博 反馈留言

	BASELINE SERUM HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL PREDICTS LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE RECEIVING CARDIAC RESYNCHRONIZATION THERAPY
	Liu, Shangyu; Mi, Jiarui; Yang, Shengwen; Hua, Wei; Liu, Zhimin; Zhang, Shu
	2017
卷号	69期号:11页码:812-812
ISSN号	0735-1097
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6368301
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Liu, Shangyu,Mi, Jiarui,Yang, Shengwen,et al. BASELINE SERUM HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL PREDICTS LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE RECEIVING CARDIAC RESYNCHRONIZATION THERAPY[J],2017,69(11):812-812.
APA	Liu, Shangyu,Mi, Jiarui,Yang, Shengwen,Hua, Wei,Liu, Zhimin,&Zhang, Shu.(2017).BASELINE SERUM HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL PREDICTS LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE RECEIVING CARDIAC RESYNCHRONIZATION THERAPY.,69(11),812-812.
MLA	Liu, Shangyu,et al."BASELINE SERUM HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL PREDICTS LONG-TERM CLINICAL OUTCOMES IN PATIENTS WITH HEART FAILURE RECEIVING CARDIAC RESYNCHRONIZATION THERAPY".69.11(2017):812-812.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。